Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study

BMJ Open
08 April 2022
https://pubmed.ncbi.nlm.nih.gov/35396307/

Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone

GlobalNewswire
27 April 2022
https://www.globenewswire.com/news-release/2022/04/27/2430707/0/en/Statera-Biopharma-and-Immune-Therapeutics-Inc-Announce-Strategic-Agreement-for-Rights-to-Low-Dose-Naltrexone.html

How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID

The Epoch Times
26 March 2022
https://www.theepochtimes.com/how-a-drug-for-opioid-and-alcohol-addiction-is-helping-treat-long-covid_4363132.html

A drug that’s helping millions of people with opioid or alcohol dependence is also being used to treat those suffering symptoms of long COVID.